Immune system modulation (Immunomodulation)

Immune system modulation involves therapeutic interventions that alter the function of the immune system to treat various diseases. This approach can either enhance immune responses (as in cancer immunotherapy) or suppress them (as in autoimmune disorders). Immunomodulators work through diverse mechanisms, targeting different components of the immune system including T cells, B cells, macrophages, and dendritic cells. They can modify immune cell activation, proliferation, differentiation, and cytokine production. Immunomodulatory strategies include pharmacological agents (like corticosteroids, DMARDs, and biologics), cellular therapies (such as CAR T-cell therapy), and biomaterial-based approaches that enable precise targeting of immune cells in specific tissues. These therapies can be designed to provide spatiotemporal control of immune responses, improving safety and efficacy compared to systemic treatments. The field of immunomodulation has seen tremendous growth in recent years, with applications expanding beyond traditional areas like transplantation and autoimmunity to include cancer treatment, infectious diseases, and age-related immune dysfunction. Modern approaches increasingly focus on targeted modulation of specific immune pathways rather than broad immunosuppression or stimulation, allowing for more precise therapeutic interventions with fewer side effects.

Other names

ImmunomodulationImmune response modificationImmune system regulation

Suppression of immune response, Enhancement of immune response, Targeting specific immune cell subsets, Modulation of cytokine production, Inhibition of inflammatory pathways, Regulation of T cell function, Modification of antigen presentation, Blocking immune checkpoint pathways, Altering signaling cascades, Targeting transcription factors